Hind Bio Sciences
Ticker > Company >

Hind Bio Sciences share price

Hindustan Bio Sciences Ltd.

  15.46 K   14   1 BSE: 532041 SECTOR: Pharmaceuticals & Drugs

7.24
+0.42 (6.16%)
BSE: 25 Aug 4:00 PM

Buy on Angel One

Price Summary

Today's High

₹ 7.4

Today's Low

₹ 6.56

52 Week High

₹ 9.92

52 Week Low

₹ 5

FinStar is Suspended!

The FinStar rating for this company is currently unavailable due to limited data disclosure. As a micro-cap company, it may carry higher risk and limited transparency. We will update the FinStar rating once more reliable data becomes available.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

₹ 7.42 Cr.

Enterprise Value

₹ 9.92 Cr.

No. of Shares

1.03 Cr.

P/E

0

P/B

10.45

Face Value

₹ 2

Div. Yield

0 %

Book Value (TTM)

₹  0.69

CASH

₹ 0.01 Cr.

DEBT

₹ 2.51 Cr.

Promoter Holding

12.19 %

EPS (TTM)

₹  -0.2

Sales Growth

-22.75%

ROE

11.78 %

ROCE

2.94%

Profit Growth

74.83 %

Add Your Ratio

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.

PE Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

PB Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year-22.75%
3 Year23.61%
5 Year-15.99%

Profit Growth

1 Year74.83%
3 Year29.95%
5 Year4.48%

ROE%

1 Year11.78%
3 Year4.65%
5 Year-17.7%

ROCE %

1 Year2.94%
3 Year1.19%
5 Year-7.35%

Debt/Equity

2.7684

Price to Cash Flow

273.86

Interest Cover Ratio

71.1429

CFO/PAT (5 Yr. Avg.)

0

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Jun 2026 12.19 0.00
Mar 2026 12.19 0.00
Dec 2025 12.19 0.00
Sep 2025 12.19 0.00
Jun 2025 12.19 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good revenue growth of 23.6101008608111% for the Past 3 years.
  • Company has a healthy liquidity position with current ratio of 73.3015.
  • The company has a strong degree of Operating leverage, Average Operating leverage stands at 5.5125822596644.

 Limitations

  • Company has a poor ROE of 4.64566666666667% over the past 3 years.
  • Company has a poor ROCE of 1.19416666666667% over the past 3 years
  • Company has high debtor days of 198.3871.
  • The company has a low EBITDA margin of -38.6761835302522% over the past 5 years.
  • The company is trading at a high PE of 0.

Quarterly Result (All Figures in Cr.)

PARTICULARS Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
Net Sales 0.32 0 0.38 0 0
Total Expenditure 0.32 0.06 0.31 0.11 0.11
Operating Profit 0 -0.06 0.08 -0.11 -0.11
Other Income 0.01 0.01 0.02 0 0
Interest 0 0 0 0 0
Depreciation 0 0 0.01 0 0
Exceptional Items 0 0 0 0 0
Profit Before Tax 0.01 -0.06 0.08 -0.12 -0.11
Tax 0 0 0 0 0
Profit After Tax 0.01 -0.06 0.08 -0.12 -0.11
Adjusted EPS (Rs) 0.01 -0.06 0.08 -0.11 -0.11

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales 1.03 0.43 0.92 1.05 0.81
Total Expenditure 1.97 0.94 0.95 0.99 0.71
Operating Profit -0.94 -0.51 -0.03 0.06 0.1
Other Income 0 0 0 0 0
Interest 0.01 0 0 0 0
Depreciation 0.01 0 0.01 0.01 0
Exceptional Items 0 0 0 0 0
Profit Before Tax -0.96 -0.51 -0.04 0.05 0.1
Tax -0.02 0 0 0 0
Net Profit -0.94 -0.52 -0.04 0.06 0.1
Adjusted EPS (Rs.) -0.92 -0.5 -0.04 0.06 0.1

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity and Liabilities
Share Capital 10.25 10.25 2.05 2.05 2.05
Total Reserves -8.95 -9.46 -1.3 -1.25 -1.15
Borrowings 0.73 1.07 1.12 2.56 2.51
Other N/C liabilities -0.01 -0.01 0 -0.01 -0.01
Current liabilities 1.45 1.12 1.42 0.01 0.01
Total Liabilities 3.48 2.97 3.28 3.37 3.41
Assets
Net Block 0.04 0.04 0.03 0.03 0.03
Capital WIP 0 0 0 0 0
Intangible WIP 0 0 0 0 0
Investments 0 0 0 0 0
Loans & Advances 2.39 2.39 2.39 2.39 2.39
Other N/C Assets 0 0 0 0 0
Current Assets 1.05 0.54 0.86 0.95 1
Total Assets 3.48 2.97 3.28 3.37 3.41
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Profit from operations -0.96 -0.51 -0.04 0.05 0.1
Adjustment 0.04 0.23 0.01 0.01 0
Changes in Assets & Liabilities 1.65 -0.06 -0.02 -1.47 -0.07
Tax Paid 0.02 0 0 0 0
Operating Cash Flow 0.75 -0.34 -0.05 -1.41 0.03
Investing Cash Flow 0 0 0 0 0
Financing Cash Flow -0.93 0.34 0.05 1.43 -0.05
Net Cash Flow -0.18 -0.01 0 0.03 -0.02

Corporate Actions

Investors Details

PARTICULARS Jun 2025% Sep 2025% Dec 2025% Mar 2026% Jun 2026%
promoters 12.19 12.19 12.19 12.19 12.19
j uma 0.01 0.01 0.01 0.01 0.01
j varun varma 0.02 0.02 0.02 0.02 0.02
super solutions india pri... 2.78 2.78 2.78 2.78 2.78
venkata rama mohan raju j... 9.39 9.39 9.39 9.39 9.39
PARTICULARS Jun 2025% Sep 2025% Dec 2025% Mar 2026% Jun 2026%
investors 87.81 87.81 87.81 87.81 87.81
bosco armando menezes 1.08 1.66 2.49 2.63 2.71
chintalapati deepika 1.37 1.37 1.37 1.37 1.37
danlaw systems india l... 1.30 1.30 - - 1.30
emily bosco menezes 1.54 1.69 2.49 2.49 2.49
llp - 0.20 0.20 0.20 0.16
madhusudan rao polineni 1.61 1.61 1.61 1.61 1.61
satyasai kolli 2.59 2.59 2.59 2.59 2.59
smitha polineni - - - 1.08 1.08
vandana yogesh bhosale 1.65 1.76 - - -

Annual Reports

Title Link
Title Link
Annual Report 2021
Annual Report 2020
Annual Report 2019
Annual Report 2018
Annual Report 2017

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
 No Credit reports exist for this company.Report us
TYPE AGENCY Link
TYPE AGENCY Link
 No Research reports exist for this company.Report us

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Concall related to this company.Report us
TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Presentation related to this company.Report us

Company News

Hind Bio Sciences - Quaterly Results 1 Aug, 12:00 AM Hindustan Bio Sciences informs about newspaper publication 2 Jun, 5:36 PM Hind Bio Science - Quaterly Results 1 Feb, 12:00 AM Hindustan Bio Sciences informs about special window 17 Dec, 5:41 PM Hind Bio Science - Quaterly Results 1 Nov, 12:00 AM Hindustan Bio Sciences informs about outcome of board meeting 31 Oct, 5:11 PM Hind Bio Science - Quaterly Results 31 Jul, 5:01 PM Hind Bio Science - Quaterly Results 31 Jul, 5:01 PM Hind Bio Science - Quaterly Results 31 Jul, 5:01 PM Hindustan Bio Sciences informs about secretarial compliance report 24 May, 4:09 PM Hindustan Bio Sciences informs about integrated filing 4 Mar, 5:31 PM Hind Bio Science - Quaterly Results 30 Jan, 3:01 PM Hind Bio Science - Quaterly Results 30 Jan, 3:01 PM Hind Bio Science - Quaterly Results 30 Jan, 3:01 PM Hind Bio Science - Quaterly Results 30 Oct, 5:08 PM Hind Bio Science - Quaterly Results 30 Oct, 5:08 PM Hind Bio Science - Quaterly Results 30 Oct, 5:08 PM Hind Bio Science - Quaterly Results 31 Jul, 2:48 PM Hind Bio Science - Quaterly Results 31 Jul, 2:48 PM Hind Bio Science - Quaterly Results 31 Jul, 2:48 PM Hind Bio Science - Quaterly Results 25 May, 12:00 PM Hind Bio Science - Quaterly Results 31 Jan, 2:30 PM Hind Bio Science - Quaterly Results 31 Jan, 2:30 PM Hind Bio Science - Quaterly Results 31 Oct, 3:20 PM Hind Bio Science - Quaterly Results 31 Oct, 3:20 PM Hind Bio Science - Quaterly Results 31 Jul, 3:03 PM Hind Bio Science - Quaterly Results 31 Jul, 3:03 PM Hind Bio Science - Quaterly Results 31 Jul, 3:03 PM Hindustan Bio Sciences informs about outcome of board meeting 10 Mar, 3:07 PM Hind Bio Science - Quaterly Results 31 Jan, 3:52 PM Hind Bio Science - Quaterly Results 31 Jan, 3:52 PM Hind Bio Science - Quaterly Results 31 Jan, 3:52 PM Hindustan Bio Sciences informs about on related party transaction 28 Dec, 5:17 PM Hind Bio Science - Quaterly Results 31 Oct, 3:49 PM Hind Bio Science - Quaterly Results 31 Oct, 3:49 PM Hind Bio Science - Quaterly Results 31 Oct, 3:49 PM Hind Bio Science - Quaterly Results 29 Jul, 4:06 PM Hind Bio Science - Quaterly Results 29 Jul, 4:06 PM Hind Bio Science - Quaterly Results 29 Jul, 4:06 PM Hindustan Biosciences informs about revised compliance certificate 4 Jun, 3:17 PM Hindustan Bio Sciences informs about compliance certificate 18 Apr, 5:19 PM Hind Bio Science - Quaterly Results 4 Feb, 3:12 PM Hind Bio Science - Quaterly Results 4 Feb, 3:12 PM Hind Bio Science - Quaterly Results 4 Feb, 3:12 PM Hindustan Biosciences informs about board meeting 24 Jan, 4:56 PM Hindustan Bio Sciences informs about certificate 20 Jan, 4:22 PM Hindustan Bio sciences informs about certificate 23 Oct, 11:42 AM Hindustan Bio Sciences informs about voting results 23 Jul, 1:01 PM Hindustan Bio Sciences informs about newspaper publication 7 May, 2:28 PM Hindustan Bio Sciences informs about certificate 16 Oct, 3:13 PM

Hind Bio Sciences Stock Price Analysis and Quick Research Report. Is Hind Bio Sciences an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Hind Bio Sciences. 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Hind Bio Sciences has a PE ratio of -35.6826022671267 which is low and comparatively undervalued.

  • Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Hind Bio Sciences has ROA of 2.9702% which is a bad sign for future performance. (Higher values are always desirable.)

  • Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Hind Bio Sciences has a Current ratio of 73.3015.

  • Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Hind Bio Sciences has a ROE of 11.784%. (Higher is better)

  • Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Hind Bio Sciences has a Debt to Equity ratio of 2.7684 which means that the company has high proportion of debt in its capital.

  • Sales growth: Hind Bio Sciences has reported revenue growth of -22.7489% which is poor in relation to its growth and performance. 

  • Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Hind Bio Sciences for the current financial year is 12.2709947128981%.

  • Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Hind Bio Sciences is Rs 0 and the yield is 0%.

  • Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Hind Bio Sciences is Rs -0.2029. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Hind Bio Sciences in Ticker for free. Also, one can get the intrinsic value of Hind Bio Sciences by using Valuation Calculators, which are available with a Finology ONE subscription. 

Hind Bio Sciences FAQs

Q1. What is Hind Bio Sciences share price today?
Ans: The current share price of Hind Bio Sciences is Rs 7.24.

Q2. What is the market capitalisation of Hind Bio Sciences?
Ans: Hind Bio Sciences has a market capitalisation of Rs 7.4215792 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Hind Bio Sciences?
Ans: The PE ratio of Hind Bio Sciences is -35.6826022671267 and the P/B ratio of Hind Bio Sciences is 10.4548736462094, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Hind Bio Sciences share?
Ans: The 52-week high share price of Hind Bio Sciences is Rs 9.92, and the 52-week low share price of Hind Bio Sciences is Rs 5.

Q5. Does Hind Bio Sciences pay dividends?
Ans: Currently, Hind Bio Sciences does not pay dividends. Dividend yield of Hind Bio Sciences is around 0%.

Q6. What are the face value and book value of Hind Bio Sciences shares?
Ans: The face value of Hind Bio Sciences shares is Rs 2, while the book value per share of Hind Bio Sciences is around Rs 0.6925. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Hind Bio Sciences?
Ans: Hind Bio Sciences has a total debt of Rs 2.5051 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Hind Bio Sciences?
Ans: The ROE of Hind Bio Sciences is 11.784% and ROCE of Hind Bio Sciences is 2.9422%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Hind Bio Sciences a good buy for the long term?
Ans: The Hind Bio Sciences long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Hind Bio Sciences undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Hind Bio Sciences appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Hind Bio Sciences’s financials?
Ans: You can review Hind Bio Sciences’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.

Last Updated on:
Brief about Hind Bio Sciences
X